Page 4 | Certara

Video

Certara IQ™: Predicting Recommended Phase 2 Doses with Confidence

Learn how Certara IQ predicts recommended Phase 2 doses using advanced QSP modeling workflows that…

CertaraOctober 16, 2025

Video

Certara IQ™: Model-Informed First-In-Human (FIH) Dose Selection

Discover how Certara IQ uses QSP modeling to predict safe and effective First-In-Human doses, accelerating…

CertaraOctober 16, 2025

Video

Inside Certara IQ™: Building the Future of QSP with Josh Apgar & Chris Bouton

Hear from Certara experts on how Certara IQ modernizes QSP modeling with AI, collaboration tools,…

CertaraOctober 16, 2025

Blog

From Cost Center to Value Driver: Making the Case for Total Value of Ownership (TVO) in Life Sciences

Shift from Total Cost of Ownership to Total Value of Ownership in life sciences, showcasing…

CertaraOctober 16, 2025

Blog

Streamlining PK/PD Reporting: A Smarter Approach to Generating Tables, Figures and Listings

Discover how TFL Studio accelerates PK/PD reporting. Create audit-ready tables, figures, and listings faster with…

CertaraOctober 16, 2025

Publication

Effective Visualizations Using “vachette” to Assess and Communicate Pharmacometric Model Results

Explore comprehensive population pharmacokinetic analyses of belantamab mafodotin, evaluating both monotherapy and combination regimens in…

CertaraOctober 15, 2025

Live Events

PKUK 2025 Pre-Conference Workshop: Modeling & Simulation Updates – QSP and PK/PD Software

CertaraOctober 14, 2025

Webinar

Model-Informed Drug Development (MIDD) as a tool to Enhance Asset Value and Address Key Investor Concerns

US (ET): Thursday, November 6, 11:00am – 11:30am EMEA (GMT): Thursday, November 13, 10:00am –…

Danielle PillsburyOctober 10, 2025

Press Release

Certara to Report Third Quarter 2025 Financial Results on November 6th, 2025

Certara to report third quarter 2025 financial results on November 6th, 2025. Company management to…

CertaraOctober 10, 2025

Webinar

RAPS Sponsored Webinar: Planning and Preparing Regulatory Submissions Using Top-down Messaging

CertaraOctober 9, 2025

Certara IQ™: Predicting Recommended Phase 2 Doses with Confidence

Certara IQ™: Model-Informed First-In-Human (FIH) Dose Selection

Inside Certara IQ™: Building the Future of QSP with Josh Apgar & Chris Bouton

From Cost Center to Value Driver: Making the Case for Total Value of Ownership (TVO) in Life Sciences

Streamlining PK/PD Reporting: A Smarter Approach to Generating Tables, Figures and Listings

Effective Visualizations Using “vachette” to Assess and Communicate Pharmacometric Model Results

PKUK 2025 Pre-Conference Workshop: Modeling & Simulation Updates – QSP and PK/PD Software

Model-Informed Drug Development (MIDD) as a tool to Enhance Asset Value and Address Key Investor Concerns

Certara to Report Third Quarter 2025 Financial Results on November 6th, 2025

RAPS Sponsored Webinar: Planning and Preparing Regulatory Submissions Using Top-down Messaging

Newsletter sign up

Quick links

Solutions

Contact